Himmel's Gold Bond limited superiority claim substantiated in NAD review.
This article was originally published in The Tan Sheet
Executive Summary
HIMMEL GOLD BOND ITCH RELIEF SUPERIORITY AT 10 MINUTES SUBSTANTIATED for use in ad claims, the National Advertising Division of the Council of Better Business Bureaus ruled in a case report published Feb. 8. NAD disagreed with a challenge from Combe, Inc., marketer of Lanacane Anesthetic Creme Medication. The watchdog organization concluded that "based on its comparative medical itch testing, the advertiser had a reasonable basis" for claiming that Gold Bond provides more effective itch relief at 10 minutes after application.